Apr 11, 2022 / 03:00PM GMT
Gil Blum - Needham & Company, LLC - Analyst
Good morning, everybody, and thank you for joining us at the Needham & Company Healthcare Conference. My name is Gil Blum and I am a senior biotech analyst here at Needham, and I cover the immuno-oncology and gene therapy subsectors.
It is my pleasure to have with me today Geoff McDonough, CEO of Generation Bio. So as a reminder to our viewers, any viewers who are watching through our conference portal are able to submit questions via the ask a question box below the video feed window.
So, Geoff, for those who are kind of new to the story, could you please provide us kind of an introductory conversation about the components of GBIO's technology, specifically ceDNA and ctLNP?
Geoff McDonough - Generation Bio Co. - President & CEO
Yes. First, let's start by saying a big thank you, Gil, for the invitation. It's always fun to chat and it's great to have a few minutes here together, especially with this kind of informal setting. We are going to get to a lot of interesting material.
Generation Bio Co at Needham Healthcare Conference (Virtual) Transcript
Apr 11, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers